Emerging markets "not as attractive as they seem"
This article was originally published in Scrip
Executive Summary
The emerging markets may not be as lucrative as they are being made out to be, at least in the short-term, and are expected to attain critical size only by around 2014, according to a new study by Mehta Partners.
You may also be interested in...
Carlyle Pays Almost $500m For A Fifth Of Piramal Pharma
Private equity group Carlyle has acquired 20% of Piramal’s pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.
Tripartite Avigan Alliance Aims For Global Access
Fujifilm Toyama seals three-way deal to accelerate the development and global supply of favipiravir, close on the heels of the arrival of a generic version of the antiviral in India under restricted emergency use for the treatment of COVID-19.
Glenmark Sanguine On Ichnos Capital Raise Plan Amid Mixed Dermatitis Data
Glenmark’s innovation spin-out initiates efforts to raise capital in the US, unfazed by mixed top-line results for its investigational atopic dermatitis treatment. Its parent firm has underscored the value proposition of the oncology franchise and proprietary bispecific antibody technology platform.
Need a specific report? 1000+ reports available
Buy Reports